Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Wa^ington Headquarters Senrfces, Directorate for Infomiation Operations and Reports, 1215 Jefferson Davis Highway, Suite 1204, Ariington, VA 22202-4302, and
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES)University of South Carolina Research Foundation Columbia, South Carolina 29208 E-Mail: lmills@cop. sc. edu My studies have compared the carcinogenic effects of an Ei-ivp-fatty acid ester preparation, E2 and 4-OH-E2 in the breast, pituitary and uterus of ACI rats. Results showed that chronic administration of an Ea-lVP-fatty acid ester preparation to these rats preferentially induces the development of mammary tumors while chronic administration of E2 results in the preferential formation of pituitary tumors. The chronic administration of 4-OH-E2 to intact female ACI rats did not induce the formation of mammary or pituitary tumors, although there was hyperplasia present in the mammary glands. These results are the first report demonstrating that chronic administration of an estrogen fatty acid ester selectively induces the development of mammary tumors in this animal model. In order to study the carcinogenic activity of other estrogen fatty acid esters, such as those of 4-OH-E2, they must first be synthesized. Therefore, a facile method for the chemical synthesis of large amounts of 4-hydroxyestradiol-17p-stearate, a representative fatty acid ester of the strongly-procarcinogenic estrogen metabolite 4-hydroxyestradiol, has been developed with estrone as the starting material. The ready availability of large amounts of chemically-synthesized 4-hydroxyestradiol-IVP-fatty acid esters make it possible for future studies to systematically characterize their hormonal and carcinogenic potency and efficacy. Appendices 11
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES)U
SUBJECT TERMS
INTRODUCTIONExogenous administration of estrogens has been shown to induce tumor formation in animals (Nandi et al, 1995;Clifton and Meyer, 1956;Kirkman, 1959;Cutts and Noble, 1964;Newbold et al, 1990; and Li and Li, 1996). In humans, there is strong evidence showing that chronic estrogen administration more readily correlates with an increase in uterine cancer risk than breast cancer risk (Ziel and Finkle, 1975; Sitteri, et al., 1976;. Although the difference is not fully understood, it is possible that some of the biologically active estrogen derivatives, such the estrogen fatty acid esters, may play a more significant role than estradiol-17|32 in the induction of breast cancer.Recently it was suggested that the mammary adipocytes may serve as a storage site for the lipoidal estrogen fatty acid este...